OpenAlex
PricingAboutJobs
Log inGet started
Work

Gefitinib in Patients with Malignant Mesothelioma: A Phase II Study by the Cancer and Leukemia Group B

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
DOI: 10.1158/1078-0432.ccr-04-1940
Authors: Ramaswamy Govindan, Robert A. Kratzke, James E. Herndon, Gloria A. Niehans, Robin Vollmer, Dorothy Watson, Mark R. Green, Hedy L. Kindler, on behalf of the Cancer and Leukemia Group B (CALGB 30101)
Institutions: Washington University in St. Louis, University of Minnesota, Duke Medical Center, Medical University of South Carolina, University of Chicago
Language: English

Topic: Occupational and environmental lung diseases
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Keywords: gefitinib, malignant pleural mesothelioma, peritoneal mesothelioma, EGFR tyrosine kinase inhibitors, EGFR overexpression, failure-free survival, drug toxicity, unresectable mesothelioma
SDG: Good health and well-being

Open Access status: closed

Funder: National Cancer Institute
Award: Cancer and Leukemia Group B
OpenAlex ID: W2113954569
FWCI: 11.6
Cites: 22
Cited by: 270
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security